@xconomy.com 2 months ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com 2 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine